鐮狀細胞病
貧血的管理
中文繁體(國語)
貧血的管理
/assets/ct/7e6416ec85/images/syn_placeholder_sqr.png

鐮狀細胞病

貧血的管理

A phase 1b/2 study of the efficacy and safety of combination hydroxyurea and dose-escalated erythropoietin for treatment of anemia in sickle cell disease (ACHiEvE-SCD). (開啟新視窗)

Adeyemo TA, Kiriza N, Oluwole FT, Jelinek M, Jonassaint J, Oluwole O, Saber C, Philips BJ, Akinsanya OJD, Osunkalu VO, DeCastro LM, Novelli EM, Xu JZ

來源‎: Blood 2024;144(Suppl 1):178-9.

檢索‎: DOI

DOI碼‎: 10.1182/blood-2024-205261

https://ashpublications.org/blood/article/144/Supplement%201/178/530726/A-Phase-1b-2-Study-of-the-Efficacy-and-Safety-of (開啟新視窗)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (開啟新視窗)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

來源‎: Acta Haematol 1995;94(3):128-34.

檢索‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (開啟新視窗)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (開啟新視窗)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

來源‎: Haematologica 2006;91(8):1076-83.

檢索‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (開啟新視窗)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (開啟新視窗)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

來源‎: J Obstet Gynaecol 2007;27(1):82-3.

檢索‎: PubMed 17365469

DOI碼‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (開啟新視窗)